Aquestive Therapeutics, Inc.
AQST • NASDAQ
Aquestive Therapeutics, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Daniel Barber, with a market cap of $512.4M.
CEODaniel Barber
Market Cap$512.4M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees135.0
Websiteaquestive.com
Next Earnings
Upcoming earnings announcement for Aquestive Therapeutics, Inc.
Date
Monday, May 11, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Revenue Estimate
$10.9M
Earnings History
Past 12 earnings reports for Aquestive Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | -$0.15Est: -$0.12 | -25.0% | $13.0MEst: $13.3M | -2.3% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.14Est: -$0.12 | -16.7% | $12.8MEst: $13.1M | -2.3% | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.14Est: -$0.18 | +22.2% | $10.0MEst: $11.2M | -10.8% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.24Est: -$0.16 | -50.0% | $8.7MEst: $12.2M | -28.7% | 10-Q |
| Mar 5, 2025 | Q4 2024 | -$0.19Est: -$0.13 | -46.2% | $11.9MEst: $13.1M | -9.5% | 10-K |
| Nov 4, 2024 | Q3 2024 | -$0.13Est: -$0.13 | 0.0% | $13.5MEst: $12.7M | +6.8% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.03Est: -$0.12 | +75.0% | $20.1MEst: $12.4M | +62.4% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.17Est: -$0.08 | -112.5% | $12.1MEst: $12.3M | -1.7% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.10Est: -$0.08 | -25.0% | $13.2MEst: $11.6M | +13.6% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.03Est: -$0.11 | +72.7% | $13.0MEst: $11.5M | +13.0% | — |
| Aug 7, 2023 | Q2 2023 | -$0.10Est: -$0.11 | +9.1% | $13.2MEst: $10.8M | +23.1% | 10-Q |
| May 2, 2023 | Q1 2023 | $0.11Est: -$0.19 | +157.9% | $11.1MEst: $9.9M | +12.0% | — |